ArticleJournal of health, population, and nutrition2026
Gobal, regional, and national burden of hepato-pancreato-biliary cancers in older populations, 1992-2021, and prediction to 2040: analysis of data from the Global Burden of Disease study, 2021.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundHepato-pancreato-biliary (HPB) cancers affect human health and impose a significant burden on older adults. However, a comprehensive assessment of the global HPB disease burden in older adults is lacking.
objectiveThis research analyzed the trends in the burden of these cancers in older adults (aged 60-89 years) from 1992 to 2021 using data from the Global Burden of Disease Study (GBD) 2021.
methodsWe examined the incidence, mortality, and disability-adjusted life years (DALYs) of liver cancer (LC), gallbladder and biliary tract cancer (GBTC), and pancreatic cancer (PC) in 204 countries and territories. Temporal trends were assessed using joinpoint regression and decomposition analysis with a focus on key global, regional, and national patterns.
resultsThe incidence and mortality rates of LC and PC showed a consistent increase, particularly in regions with a high Socio-Demographic Index (SDI), whereas GBTC rates declined globally. Metabolic risk factors such as high Body Mass Index (BMI) were associated with increased DALYs for LC and PC. Projections indicate that the burden of these cancers will continue to increase.
conclusionOur findings highlight the significant global disparities in the burden of HPB cancers among older adults, underscoring the need for targeted prevention and treatment strategies, particularly in regions with high SDIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.